Vik Chandra, CEO of uMETHOD, talked with Fox News Digital about how his company's AI tool, RestoreU, is helping physicians pinpoint better treatment plans for their dementia patients. More than six million Americans are living with Alzheimer's disease -- and one in three seniors dies with the disease, according to statistics from the Alzheimer's Association. With so many different factors -- genetics, lifestyle and environment -- influencing a person's risk of developing Alzheimer's, many doctors are moving away from one-size-fits-all approaches and calling for more individualized treatments. It's a concept known as precision medicine. And it's what inspired a company called uMETHOD to create RestoreU, a tool that uses artificial intelligence to help physicians create personalized care plans for patients with Alzheimer's and other types of dementia.

IBM (NYSE:IBM) plans to develop and apply machine learning techniques to years of research data in the hopes of identifying factors that trigger the onset of Type I diabetes in children, with the support of JDRF. Scientists at IBM are slated to assess three different data sets using machine learning algorithms to find patterns and factors that could one day help delay or prevent Type I diabetes. Get the full story at our sister site, Drug Delivery Business News.